Trial Profile
Vinorelbine Plus Gemcitabine (VG) Versus Vinorelbine Plus Carboplatin (VC) in Advanced Non-Small Cell Lung Cancer. An Open Randomized Multicenter Phase III Trial From Norwegian Lung Cancer Study Group (NLCG).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Aug 2020
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Vinorelbine (Primary) ; Carboplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 03 Jul 2012 Results published in the British Journal of Cancer.
- 01 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Apr 2011 Actual end date (February 2011) added as reported by ClinicalTrials.gov.